Literature DB >> 11072439

Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior.

A R Buchhalter1, T Eissenberg.   

Abstract

Tobacco companies are responding to public pressure to market less dangerous and aversive products by developing novel smoking systems. The short- and long-term effects of these systems must be evaluated to determine the risks inherent in their use. One such system, the Accord, uses a hand-held device to heat tobacco electronically and is marketed as a means to reduce second-hand smoke. In this study 10 cigarette smokers (> or = 10 cigarettes per day) were recruited to evaluate the short-term effects produced when using this system. Subjects abstained from smoking for at least 8 h before participating in two experimental sessions where they smoked either their usual brand or used the Accord at 30-min intervals for 2 hours. Subject-rated measures of tobacco withdrawal and craving, physiological measures, and smoking behavior were assessed within each session. Results show that, when using the Accord, the magnitude of smoking-induced craving reductions and the physiological effects of smoking were less, and puff volume and frequency were greater than when subjects smoked their own brand of cigarettes. The expired air carbon monoxide increases observed after smoking own brand cigarettes did not occur after using the Accord. The novel system does not provide maximal withdrawal suppression and produces little increase in expired air carbon monoxide; physiological data suggest that the novel system may deliver nicotine less efficiently than normally marketed cigarettes. Smokers using the Accord system may smoke more often or more intensely to compensate for decreased withdrawal suppression and/or nicotine delivery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072439     DOI: 10.1080/14622200050011286

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  15 in total

1.  Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Authors:  Jennifer N Gray; Alison B Breland; Michael Weaver; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2008-09       Impact factor: 4.244

2.  Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation.

Authors:  Melissa D Blank; Steven Disharoon; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2009-06-11       Impact factor: 4.244

Review 3.  Measures for assessing subjective effects of potential reduced-exposure products.

Authors:  Karen Hanson; Richard O'Connor; Dorothy Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

4.  Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges.

Authors:  Melissa D Blank; Alison B Breland; Caroline O Cobb; Tory Spindle; Carolina Ramôa; Thomas Eissenberg
Journal:  Tob Regul Sci       Date:  2016-10

5.  Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers.

Authors:  Alexa A Lopez; Marzena Hiler; Sarah Maloney; Thomas Eissenberg; Alison B Breland
Journal:  Drug Alcohol Depend       Date:  2016-10-11       Impact factor: 4.492

Review 6.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 7.  Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods.

Authors:  Vaughan W Rees; Jennifer M Kreslake; K Michael Cummings; Richard J O'Connor; Dorothy K Hatsukami; Mark Parascandola; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 8.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 9.  Developing the science base for reducing tobacco harm.

Authors:  Dorothy K Hatsukami; Anne M Joseph; Mark Lesage; Joni Jensen; Sharon E Murphy; Paul R Pentel; Michael Kotlyar; Eugene Borgida; Chap Le; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

10.  Acute effects of JUUL and IQOS in cigarette smokers.

Authors:  Sarah Maloney; Alisha Eversole; Melanie Crabtree; Eric Soule; Thomas Eissenberg; Alison Breland
Journal:  Tob Control       Date:  2020-02-10       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.